Use of Beetroot Juice to Protect Against Postoperative Ileus (POI) Following Colorectal Surgery: a Pilot Study. (BEET IT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Wim Ceelen
- Phone Number: +32(0)93326251
- Email: wim.ceelen@ugent.be
Study Contact Backup
- Name: Sarah Cosyns
- Phone Number: +32(0)93321562
- Email: sarah.cosyns@ugent.be
Study Locations
-
-
-
Gent, Belgium, 9000
- Ghent University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• All patients undergoing colonic or upper rectum laparoscopic surgery.
Exclusion Criteria:
- Pregnancy or breast feeding
- Psychiatric pathology capable of affecting comprehension and judgment faculty
- History of metastatic disease
- History of prior abdominal bowel surgery
- Abdominal radiation treatment
- Chronic constipation (defined as two or fewer bowel movements per week)
- Gut motility influencing agents (e.g. tricyclic antidepressants, chronic use of laxatives)
- Frequent use of mouthwash, as this affects the enterosalivary circulation of nitrate
- Current use of broad-spectrum antibiotics, which will affect the oral flora and likely affect the nitrate reductase activity
- More than one bowel anastomosis during this surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Beetroot juice
|
Patients will drink 70 ml of beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
|
Placebo Comparator: Control group 1
|
Patients will drink 70 ml of nitrate-depleted beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
|
Sham Comparator: Control group 2
|
Patients will drink 70 ml of water in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time until recovery of gastrointestinal function.
Time Frame: up to 30 days after surgery
|
Recovery of gastrointestinal function is defined as the interval (in days) from the end of surgery until passage of stool AND tolerance of solid food.
|
up to 30 days after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time until passage of stool, flatus or until tolerance of (semi-)solid oral diet (in days).
Time Frame: up to 30 days after surgery
|
up to 30 days after surgery
|
|
|
Overall post-operative complication rate defined according to the Clavien-Dindo Classification.
Time Frame: 3 months postoperatively
|
3 months postoperatively
|
|
|
Presence of prolonged postoperative ileus.
Time Frame: up to 30 days after surgery
|
Prolonged postoperative ileus is defined as presence of 2 or more of the following criteria on or after day 4 postoperatively: nausea or vomiting, inability to tolerate a solid or semi-solid oral diet, abdominal distension, absence of flatus and stool, radiological evidence of ileus.
|
up to 30 days after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- EC/2017/1476
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.